Protara Therapeutics, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Protara Therapeutics, Inc. (TARA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $57.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-10
- Protara Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $57.31M, a 28.67% increase from fiscal 2024.
- Protara Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $44.54M.
- Protara Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was -$14.96M.
- Protara Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2018 was -$17.86M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $57.31M 10-K · filed 2026-03-10 |
| 2024-12-31 | $44.54M 10-K · filed 2026-03-10 |
| 2019-12-31 | -$14.96M 10-K · filed 2020-03-20 |
| 2018-12-31 | -$17.86M 10-K · filed 2020-03-20 |
| 2017-12-31 | -$24.80M 10-K · filed 2019-03-13 |
| 2016-12-31 | -$15.86M 10-K · filed 2019-03-13 |
| 2015-12-31 | -$21.38M 10-K · filed 2018-03-14 |
| 2014-12-31 | -$3.34M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |